These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25401338)

  • 1. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
    Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
    Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.
    Zahavi T; Lanton T; Divon MS; Salmon A; Peretz T; Galun E; Axelrod JH; Sonnenblick A
    Oncotarget; 2016 Jan; 7(4):4860-70. PubMed ID: 26695439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
    Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
    Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation.
    Rozenblum N; Zeira E; Scaiewicz V; Bulvik B; Gourevitch S; Yotvat H; Galun E; Goldberg SN
    Radiology; 2015 Aug; 276(2):426-32. PubMed ID: 26203709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
    Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
    Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
    Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
    Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
    Ma NF; Hu L; Fung JM; Xie D; Zheng BJ; Chen L; Tang DJ; Fu L; Wu Z; Chen M; Fang Y; Guan XY
    Hepatology; 2008 Feb; 47(2):503-10. PubMed ID: 18023026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome.
    Paradis V; Albuquerque M; Mebarki M; Hernandez L; Zalinski S; Quentin S; Belghiti J; Soulier J; Bedossa P
    Gut; 2013 Jun; 62(6):911-9. PubMed ID: 22942238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
    Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
    J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.
    Canter RJ; Patel SA; Kennedy T; D'Angelica MI; Jarnagin WR; Fong Y; Blumgart LH; Freeman RB; DeMatteo RP; Abt PL
    Am J Clin Oncol; 2011 Oct; 34(5):466-71. PubMed ID: 20938319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
    Wilkens L; Hammer C; Glombitza S; Müller DE
    Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct set of chromosomal aberrations in childhood hepatocellular carcinoma is correlated to hepatitis B virus infection.
    Tan L; Meier T; Kuhlmann M; Xie F; Baier C; Zhu Z; Cong WM; Wilkens L
    Cancer Genet; 2016 Mar; 209(3):87-96. PubMed ID: 26837720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
    Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
    Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.